Literature DB >> 2302199

Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin.

S Chou1, M Kaneko, K Nakaya, Y Nakamura.   

Abstract

Low concentrations of camptothecin induced differentiation of human and mouse myeloid leukemia cells including human HL60, U937, ML1, and K562 cells and mouse M1 cells as measured by various differentiation-associated properties. When K562 cells were pretreated with 20 nM camptothecin for 2 h, 53% of the cells were induced to differentiate as measured by NBT staining. Significant single strand breaks in DNA of K562 cells were caused by this treatment. Most single strand breaks were accompanied by protein-DNA cross linking. The combination of camptothecin and rTNF synergistically induced differentiation of human ML1, U937, and M1 cells. These results suggest that topo I may be important in some differentiation of myeloid leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302199     DOI: 10.1016/0006-291x(90)91925-i

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors:  C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells.

Authors:  Y Jing; H Ohizumi; N Kawazoe; S Hashimoto; Y Masuda; S Nakajo; T Yoshida; Y Kuroiwa; K Nakaya
Journal:  Jpn J Cancer Res       Date:  1994-06

3.  Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells.

Authors:  K Nakaya; S Chou; M Kaneko; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  1991-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.